Advertisement

Topics

Takara Shuzo Co., Ltd Company Profile

12:07 EDT 23rd June 2018 | BioPortfolio

Takara Bio started when Takara Shuzo Co., Ltd. (which is now Takara Holdings Inc.) established the Central Research Institute and launched the bio-related business in 1967. Our genetic engineering business was launched in 1979 when we started sales of first domestically produced restriction enzymes that identify DNA sequences and cut DNA at a specific location, which are essential reagents for genetic engineering research. In 1988 we introduced the PCR method, by which a few fragments of DNA can be amplified more than one million times in a short amount of time, for the first time in Japan, and we have sold PCR-related reagents and instruments since then. Besides, we were the first in Japan to promote the DNA chip technology, which is used in gene expression analysis. Takara Bio has been contributing to the genetic engineering research and development in Japan by introducing key biotechnologies to researchers. In recent years, the range of application of genetic engineering has been expanding; in ex vivo gene therapy in particular, we developed RetroNectin method, which has now become a world standard, and it is now starting to be used in gene therapies for treatment of refractory diseases such as AIDS and cancer at research institutions all over the world including National Cancer Center in Japan, the National Cancer Institute in the U.S., and French National Institute of Health and Medical Research.

Location

Seta 3-4-1
Otsu
Shiga
Japan

Contact

Phone: 81 77-543-7200
Fax: 81 77-543-2494


News Articles [16 Associated News Articles listed on BioPortfolio]

Otsuka and Takara to co-develop and sell two cancer therapies

Otsuka Pharmaceutical has entered an agreement with Takara Bio for the co-development and exclusive sales rights in Japan for two...Read More... The post Otsuka and Takara to co-develop and sell two c...

Otsuka and Takara team up to develop gene therapy candidates in oncology

Tokyo’s Otsuka Pharmaceutical has entered into an agreement with fellow Japanese firm Takara Bio (TYO:…

Otsuka gets Japanese rights to Takara's TCR, CAR therapies

Takara: Editing Human iPSCs with CRISPR-Cas9 and Single-Cell Cloning

Visualize the workflow.

Global PCR Reagent Market Survey and Trend Research 2018 [Report Updated: 25012018] Prices from USD $2600

SummaryThis report describes the development of the industry by upstream downstream, industry overall and development, key companies, as well as type segment market application and so on, and makes ...

Clontech Laboratories, Inc.

Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As the newest member of the Takara Bio Group, Clonte...

Takara Bio Inc 4974 Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryTakara Bio Inc Takara, a subsidiary of Takara Holdings Inc is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments. The company sel...

Takara Bio Inc 4974 Medical Equipment Deals and Alliances Profile [Report Updated: 09022018] Prices from USD $250

SummaryTakara Bio Inc Takara, a subsidiary of Takara Holdings Inc is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments. The company sel...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Takara Shuzo Co., Ltd

Takara Bio started when Takara Shuzo Co., Ltd. (which is now Takara Holdings Inc.) established the Central Research Institute and launched the bio-related business in 1967. Our genetic engineering bus...

Clontech Laboratories, Inc.

Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of life science research reagents under the Clontech and Takara brands. ...

BD Clontech

Clontech Laboratories, Inc. develops, produces, and markets innovative biological products to the life science market worldwide. Clontech is a wholly owned subsidiary of Takara Bio, Inc.

Clontech Laboratories, Inc

Clontech Laboratories, Inc. develops, produces, and markets innovative biological products to the life science market worldwide. Clontech is a wholly owned subsidiary of Takara Bio, Inc.

Clontech Laboratories Incorporated

Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As the newest member of the Takara Bio Group, Clonte...

More Information about "Takara Shuzo Co., Ltd" on BioPortfolio

We have published hundreds of Takara Shuzo Co., Ltd news stories on BioPortfolio along with dozens of Takara Shuzo Co., Ltd Clinical Trials and PubMed Articles about Takara Shuzo Co., Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takara Shuzo Co., Ltd Companies in our database. You can also find out about relevant Takara Shuzo Co., Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...


Corporate Database Quicklinks



Searches Linking to this Company Record